Moneycontrol
SENSEX NIFTY
You are here : Moneycontrol > Markets > Share/Stock Price > Pharmaceuticals > Samrat Pharmachem

Samrat Pharmachem

BSE: 530125 | NSE: | ISIN: INE103E01016 | SECTOR: PHARMACEUTICALS |
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Aug 22, 12:51
52.75
-2.25 (-4.09%)
VOLUME 100
AVERAGE VOLUME
5-Day 1,960
10-Day 1,685
30-Day 1,380
VOLUME SHOCKER
5-Day 1,960
10-Day 1,685
30-Day 1,380
Prev. Close
55.00
Open Price
52.80
Bid PRICE (QTY.)
52.85 (2)
Offer PRICE (Qty.)
53.90 (1)
VWAP 52.75
Market
Depth

Market Depth (22 Aug 2017)

BUY SELL
QTY PRICE PRICE QTY
2 52.85 53.90 1
100 52.80 54.85 9
100 52.60 55.00 15
25 52.55 55.90 200
30 52.50 56.90 18
404 Total 296 Total

Buy Qty

404

Sell QTY

296

Today's Low/High 52.75 52.80
52 Wk Low/High 29.00 94.40
L/U Price Band 49.50 60.50

Samrat Pharma is not listed on NSE

Action in Samrat Pharmachem

No recommendations so far.

What's your call on Samrat Pharma today?
Read Investor view

Standalone
MARKET CAP (Rs Cr)
16.30
P/E
10.40
BOOK VALUE (Rs)
49.59
DIV (%)
0.00%
Market Lot
1
INDUSTRY P/E
26.73
EPS (TTM)
5.07
P/C
7.21
PRICE/BOOK
1.06
DIV YIELD.(%)
-%
FACE VALUE (Rs)
10.00
DELIVERABLES (%)
100 new
DELIVERY AVERAGES
3-Day 93.11%
5-Day 68.56%
8-Day 76.30%
* Note - Trailing EPS is displayed only when latest 4 quarter results are available.
Track Samrat Pharma on the go with the moneycontrol app
Also available for
UPCOMING CORPORATE ACTION
Board Meeting
on 13-Sep-2017 (Quarterly Results)
EXPAND ALL COLLAPSE ALL

Top Trading Ideas

1 August 2017

buy

PetronetLNG Aug Fut

Entry Price (Rs)

207.60

Exit Price (Rs)

211.25

Gain (Rs)

3.00

buy

DalmiaBharat Aug Fut

Entry Price (Rs)

2,671.00

Exit Price (Rs)

2,700.00

Gain (Rs)

29.00

Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 36.05 52.80  
High Price 38.70 52.80  
Low Price 35.25 52.75  
Last Price 38.30 52.75 37.73
Volume 6,904 100 -98.55
Simple Moving Averages
Days BSE NSE
30 59.78
50 60.44
150 65.29
200 59.46

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Samrat Pharma

News/Videos & Announcements
Stock Advice & Research Reports
Stock Advice
No Advice
Research Reports
No Reports
News Across the Web
Financials
Income Statement
 Standalone Mar'17 Dec'16 Sep'16
Jun'16
Net Sales 13.04 18.11 18.65 21.27
Other Income 0.02 0.01 -0.01 0.05
PBDIT 1.05 1.21 0.92 0.62
Net Profit 0.25 0.65 0.42 0.25

Annual Report

Download in PDF format 2016 |2015 |2014 |2013 |2012 |2011 |2010
Balance Sheet
Mar'16
(In Rs Cr)
Total Share Capital 3.09
Net Worth 13.76
Total Debt 5.24
Net Block 7.28
Investments 2.00
Total Assets 19.00
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 466.10 1.21 818.25 433.15 111,831.66
Cadila Health 468.45 -0.97 558.00 342.00 47,957.22
Cipla 562.85 0.37 621.90 504.15 45,284.53
Piramal Enter 2578.45 -1.28 3083.05 1533.90 44,494.53
Lupin 940.45 1.91 1590.00 920.00 42,482.38
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Mar' 17Sep' 16Jun' 16Mar' 16
Promoter47.8747.4947.3047.46
Public (FII + DII)52.1352.5152.7052.54
Others0.000.000.000.00
Total100.00100.00100.00100.00
Mutual Funds Holding
No Mutual Funds Holding the share
Company Information
REGISTERED OFFICE
Address
Plot No A2/3445, GIDC, Phase IV,,
City
Ankleshwar
State
Gujarat
Pin Code
393002
Tel. No.
02646-220774 02646-251291
Fax No.
02646-251291
REGISTRARS
Name
Link Intime India Pvt. Ltd.
Address
C-33, Pannalal Silk Mills Compound, LBS Marg, Bhandup (W)
City
Mumbai - 400078
State
Maharashtra
Tel. No.
022-25963838, 25946970
Fax No.
022-25946969
MANAGEMENT
Name
Designation
Lalit Mehta
Chairman & M.D & CEO
Rajesh Mehta
Executive Director & CFO
Megh Mehta
Executive Director
Mahendra Pipalia
Director
Samir Kothary
Director
Message Board & Community
Right Time + Right Stock + Right Investment = HIGH PROFIT

Minda Industries Recommended on Nov 24th 2016

Recommended price 292.00  |  Peak from reco 845.90 189.25%

For more multi bagger recommendations click here

What are Multi baggers?

Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.

About Samrat Pharma

Samrat Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 16.30 crore.

The company management includes Lalit Mehta - Chairman & M.D & CEO, Rajesh Mehta - Executive Director & CFO, Megh Mehta - Executive Director, Mahendra Pipalia - Director, Samir Kothary - Director, Renu Dharod - Director.

It is listed on the BSE with a BSE Code of 530125.

Its Registered office is at Plot No A2/3445, GIDC, Phase IV,, Ankleshwar,Gujarat - 393002.

Their Registrars are Link Intime India Pvt. Ltd.

Quick Links for Samrat Pharmachem
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
Results of Samrat Pharma